Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
Chobanian, A V; Bakris, G L; Black, H R; Cushman, W C; Green, L A; Izzo, J L; Jones, D W; Materson, B J; Oparil, S; Wright, J T; Toccella, J R the National High Blood Pressure E...
h-index: Number of publications with at least h citations each.